# BioMEL- Diagnostic and Prognostic Factors in Melanoma.

> **NCT05446155** · — · RECRUITING · sponsor: **Region Skane** · enrollment: 2000 (estimated)

## Conditions studied

- Melanoma
- Melanoma in Situ
- Dysplastic Nevi
- Mole (Dermatology)
- Image
- Mutation

## Interventions

- **DIAGNOSTIC_TEST:** Imaging

## Key facts

- **NCT ID:** NCT05446155
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2013-11-04
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446155, "BioMEL- Diagnostic and Prognostic Factors in Melanoma.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05446155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*